REDWOOD CITY, Calif.–(BUSINESS WIRE)–January 2, 2018–

AEGEA Medical Inc. (“AEGEA”), a privately held medical expertise firm within the ladies’s well being house centered on the event of its patented Adaptive Vapor Ablation expertise for endometrial ablation, as we speak introduced it has closed on a $30 million financing with Perceptive Advisors (“Perceptive”). In reference to the financing, AEGEA additionally raised an extra $10 million from its present fairness buyers together with Alloy Ventures, Delphi Ventures, Medtronic, BioMed Ventures, and Solas BioVentures.

AEGEA’s Adaptive Vapor Ablation system is the primary FDA-approved endometrial ablation system particularly designed to deal with menorrhagia, or irregular uterine bleeding, within the physician’s workplace with minimal anesthesia/analgesia and fast restoration. This financing supplies substantial incremental capital to fund AEGEA’s operations whereas it prepares to launch commercially within the US.

Don Gurskis, President and CEO of AEGEA, commented, “AEGEA is at an necessary inflection level as we put together to rework the expertise for the tens of millions of ladies affected by irregular uterine bleeding, and the physicians that serve them. We are delighted to companion with Perceptive Advisors as we put together to launch this novel and disruptive expertise.”

“We are excited to be partnering with AEGEA Medical in serving to to launch this game-changing expertise within the ladies’s well being house,” mentioned Sam Chawla, Portfolio Manager at Perceptive. “We consider AEGEA’s Adaptive Vapor expertise has nice potential for addressing and increasing the marketplace for endometrial ablation, and we look ahead to working with AEGEA to realize these goals.”

Piper Jaffray & Co (“Piper Jaffray”) served as unique monetary advisor and sole placement agent in reference to the transaction.

About AEGEA Medical

AEGEA Medical is pioneering the applying of its Adaptive Vapor Ablation expertise to ship therapies that present prime quality affected person outcomes to a wider vary of sufferers. AEGEA’s FDA accepted water vapor expertise permits the supply of a secure and efficient endometrial ablation for the remedy of menorrhagia in a easy, office-based process that takes solely minutes. With a imaginative and prescient to develop secure and efficient remedy choices to extra sufferers, and supply physicians with the boldness and comfort essential to carry out office-based procedures, AEGEA is inspiring new approaches to ladies’s healthcare. Founded in 2008, AEGEA Medical is positioned in Redwood City, California. For extra details about AEGEA, go to www.aegeamedical.com.

About Perceptive Advisors

Founded in 1999 and based mostly in New York, NY, Perceptive Advisors is an funding administration agency centered on supporting the progress of the life sciences business by figuring out alternatives and directing monetary sources to probably the most promising applied sciences in healthcare. For extra details about Perceptive, go to www.perceptivelife.com.

About Piper Jaffray

Founded in 1895, Piper Jaffray Companies (NYSE: PJC) is a full-service U.S. funding financial institution and asset administration agency providing M&A advisory, funding underwriting, company funding companies and institutional brokerage. For extra details about Piper Jaffray, go to www.piperjaffray.com.

AEGEA Medical Inc.
Don Gurskis, 650-7011-1125x 402
dgurskis@aegeamedical.com

This article sources data from VentureBeat